glp-1 drug liraglutide may protect against dementia Popular obesity fails in hotly anticipated Alzheimer's trials | Science GLP-1 drug liraglutide may protect

Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database

Programs that prescribe based purely on a checkbox form did not make this list

Both medications are available in Australia, with Ozempic PBS-subsidised for diabetes and Wegovy privately available

Central modulation of pain

doi: 10.1007/s13311-021-01088-5 91 da SilvaEMYariwakeVYAlvesRWde AraujoDRAndrade-OliveiraV

Beyond metabolic regulation, GLP-1RAs exhibit potent anti-inflammatory and immunomodulatory properties that contribute to their therapeutic efficacy in MASLD